Previous studies have demonstrated that older individuals with AD presenting with cognitive symptoms in memory clinics often exhibit lower amounts of AD pathology, particularly tau pathology, partly as a result of the presence of other brain pathologies and lower cognitive reserve21. This evidence concerns the gene MAPT and Alzheimer disease.